BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-359@pharmaconomics
DTSTAMP:20260707T034241Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:PTGX Phase 1 — PN-881
DESCRIPTION:Phase 1 trial results for PN-881 in its lead indication are due Jun 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1377121/000110465926019658/tm267184d1_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/359
URL:https://www.pharmaconomics.com/e/359
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PTGX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR